2024 HCPCS Code Q0162
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
TAGS: prescription chemotherapy exceed substitute regimen approved ondansetron therapeutic complete dosage
Short Description | Ondansetron oral |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2012 |
HCPCS Code Added Date | January 01, 2012 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0144 - Azithromycin dihydrate, oral
- Q0161 - Chlorpromazine hcl 5mg oral
- Q0162 - Ondansetron oral
- Q0163 - Diphenhydramine hcl 50mg
- Q0164 - Prochlorperazine maleate 5mg
- Q0166 - Granisetron hcl 1 mg oral
- Q0167 - Dronabinol 2.5mg oral
- Q0169 - Promethazine hcl 12.5mg oral
- Q0173 - Trimethobenzamide hcl 250mg
- Q0174 - Thiethylperazine maleate10mg
- Q0175 - Perphenazine 4mg oral
- Q0177 - Hydroxyzine pamoate 25mg
- Q0180 - Dolasetron mesylate oral
- Q0181 - Unspecified oral anti-emetic
- Q0220 - Tixagev and cilgav, 300mg
- Q0221 - Tixagev and cilgav, 600mg
- Q0222 - Bebtelovimab 175 mg
- Q0224 - Inj, pemivibart, 4500 mg
- Q0239 - Bamlanivimab-xxxx
- Q0240 - Casirivi and imdevi 600 mg